May-Jun 2020;22(3):309-316
For a reference listing of reported interactions see the warfarin interaction page here
2 Moreover, PCOS may present as an irregular cycle, defined by an abnormal duration of 35 days or several cycles 35 days), the bleeding ratio, which is the number of menstrual bleedings divided by the study period in months that can aid in the detection of menstrual irregularities and the impact of treatment, increased in 62% of patients suffering from PCOS in the liraglutide (1.8 mg/day) intervention group in comparison to placebo at 28% 81 (Figure 3(b))
Orforglipron Phase 3 Results Show Promise for New GLP-1 Weight-Loss Pill (Updated 3/6/2026) A new oral weight-loss drug could soon join the rapidly evolving GLP-1 treatment landscape
doi: 10.1007/S12020-023-03487-4 100 Austregsilo de Athayde De Hollanda MoraisBMartins PrizoVde Moura de SouzaMXimenes MendesBRodrigues DefanteMLCosendey MartinsOet al
This is speculative, but it is how health economists will likely evaluate the drug once real-world pricing data becomes available